Assessing the Immunogenicity of Biopharmaceuticals
Biopharmaceuticals have the potential to raise an immunogenic response in treated individuals, which may impact the efficacy and safety profile of these drugs. As a result, it is essential to evaluate immunogenicity throughout the different phases of the clinical development of a biopharmaceutical,...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer International Publishing
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4875071/ |